Filing Details
- Accession Number:
- 0001821825-25-000025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-06 13:58:08
- Reporting Period:
- 2025-05-05
- Filing Date:
- 2025-05-06
- Accepted Time:
- 2025-05-06 13:58:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1821825 | Organon & Co. | OGN | Pharmaceutical Preparations (2834) | 464838035 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1859698 | Kevin Ali | C/O Organon &Amp; Co. 30 Hudson Street, Floor 33 Jersey City NJ 07032 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-05 | 34,000 | $8.81 | 282,731 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.765 to $8.850, inclusive. The reporting person undertakes to provide to Organon & Co. ("Organon"), any security holder of Organon, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
